Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
1.2.1. Bleeding Disorder Testing Market, by Region, 2019-2029 (USD Million)
1.2.2. Bleeding Disorder Testing Market, by Product Type, 2019-2029 (USD Million)
1.2.3. Bleeding Disorder Testing Market, by Indication, 2019-2029 (USD Million)
1.2.4. Bleeding Disorder Testing Market, by End-user, 2019-2029 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Bleeding Disorder Testing Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Bleeding Disorder Testing Market Dynamics
3.1. Bleeding Disorder Testing Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Rising integration of artificial intelligence and nanomaterials in testing and diagnosis
3.1.1.2. Increasing prevalence and diagnosis of bleeding disorder
3.1.2. Market Challenges
3.1.2.1. Low adherence to guidelines
3.1.2.2. High cost of haemophilia drugs
3.1.3. Market Opportunities
3.1.3.1. Rising introduction of new products
3.1.3.2. Growing R&D investment by the key market players
Chapter 4. Global Bleeding Disorder Testing Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Bleeding Disorder Testing Market, by Product Type
6.1. Market Snapshot
6.2. Global Bleeding Disorder Testing Market by Product Type, Performance - Potential Analysis
6.3. Global Bleeding Disorder Testing Market Estimates & Forecasts by Product Type 2019-2029 (USD Million)
6.4. Bleeding Disorder Testing Market, Sub Segment Analysis
6.4.1. Reagents & Consumables
6.4.2. Instruments
Chapter 7. Global Bleeding Disorder Testing Market, by Indication
7.1. Market Snapshot
7.2. Global Bleeding Disorder Testing Market by Indication, Performance - Potential Analysis
7.3. Global Bleeding Disorder Testing Market Estimates & Forecasts by Indication 2019-2029 (USD Million)
7.4. Bleeding Disorder Testing Market, Sub Segment Analysis
7.4.1. Hemophilia A
7.4.2. Hemophilia B
7.4.3. Von Willebrand Disease
7.4.4. Idiopathic Thrombocytopenic Purpura
7.4.5. Others
Chapter 8. Global Bleeding Disorder Testing Market, by End-user
8.1. Market Snapshot
8.2. Global Bleeding Disorder Testing Market by End-user, Performance - Potential Analysis
8.3. Global Bleeding Disorder Testing Market Estimates & Forecasts by End-user 2019-2029 (USD Million)
8.4. Bleeding Disorder Testing Market, Sub Segment Analysis
8.4.1. Hospitals & Clinics
8.4.2. Diagnostic Centers
8.4.3. Others
Chapter 9. Global Bleeding Disorder Testing Market, Regional Analysis
9.1. Bleeding Disorder Testing Market, Regional Market Snapshot
9.2. North America Bleeding Disorder Testing Market
9.2.1. U.S. Bleeding Disorder Testing Market
9.2.1.1. Product Type breakdown estimates & forecasts, 2019-2029
9.2.1.2. Indication breakdown estimates & forecasts, 2019-2029
9.2.1.3. End-user breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Bleeding Disorder Testing Market
9.3. Europe Bleeding Disorder Testing Market Snapshot
9.3.1. U.K. Bleeding Disorder Testing Market
9.3.2. Germany Bleeding Disorder Testing Market
9.3.3. France Bleeding Disorder Testing Market
9.3.4. Spain Bleeding Disorder Testing Market
9.3.5. Italy Bleeding Disorder Testing Market
9.3.6. Rest of Europe Bleeding Disorder Testing Market
9.4. Asia-Pacific Bleeding Disorder Testing Market Snapshot
9.4.1. China Bleeding Disorder Testing Market
9.4.2. India Bleeding Disorder Testing Market
9.4.3. Japan Bleeding Disorder Testing Market
9.4.4. Australia Bleeding Disorder Testing Market
9.4.5. South Korea Bleeding Disorder Testing Market
9.4.6. Rest of Asia Pacific Bleeding Disorder Testing Market
9.5. Latin America Bleeding Disorder Testing Market Snapshot
9.5.1. Brazil Bleeding Disorder Testing Market
9.5.2. Mexico Bleeding Disorder Testing Market
9.5.3. Rest of Latin America Bleeding Disorder Testing Market
9.6. Rest of The World Bleeding Disorder Testing Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. F. Hoffmann-La Roche Ltd.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Siemens Healthcare GmbH
10.2.3. HORIBA Ltd.
10.2.4. Sysmex Corporation
10.2.5. Abbott
10.2.6. Thermo Fisher Scientific Inc.
10.2.7. Biomerica, Inc.
10.2.8. Becton, Dickinson, and Company
10.2.9. Quest Diagnostics
10.2.10. Trinity Biotech Plc
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption